5 completed, 1 no longer available, 1 terminated. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow elezanumab: new trials by email Literature Review of elezanumab trials Research Report on elezanumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Multiple Sclerosis (4) · Ischemic Stroke (1) · Multiple Sclerosis, Chronic Progressive (1) · Spinal Cord Injuries (1)
AbbVie (7)
United States (5) · Canada (4) · Australia (2) · Japan (2) · South Korea (2) · Spain (2) · Israel (1) · United Kingdom (1)
2019 (2), 2015 (1)